Does Blackstone own LXEO stock?

Yes. As of its Q2 2026 13F, Blackstone holds 904,959 shares of LXEO (Lexeo Therapeutics), worth $4.2M.

How many shares of LXEO does Blackstone own?

As of its Q2 2026 13F, Blackstone holds 904,959 shares of LXEO (Lexeo Therapeutics).

As of its Q2 2026 13F, Blackstone's LXEO position is worth $4.2M.

Blackstone first reported LXEO in its Q4 2023 13F and has listed it in 11 quarterly 13F filings.

Position history for Blackstone Inc.'s holdings in LEXEO THERAPEUTICS INC

Current Value

$4.2M

Current Shares

904,959

Total Value Change

-$5.1M

Total Shares Change

+208,849

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Unchanged	904,959	0.0%	$4.2M	0.0%	$4.66	0
2026-Q1	Unchanged	904,959	0.0%	$5.2M	0.0%	$5.74	0
2025-Q4	Decreased	904,959	-19.6%	$9M	0.0%	$9.93	0
2025-Q3	Unchanged	1.1M	0.0%	$7.5M	0.0%	$6.64	0
2025-Q2	Decreased	1.1M	-2.9%	$4.5M	0.0%	$4.02	0
2025-Q1	Unchanged	1.2M	0.0%	$4M	0.0%	$3.47	0
2024-Q4	Unchanged	1.2M	0.0%	$7.6M	0.0%	$6.58	0
2024-Q3	Increased	1.2M	+43.8%	$10.5M	0.0%	$9.04	37
2024-Q2	Increased	805,757	+15.8%	$12.9M	0.1%	$16.04	32
2024-Q1	Unchanged	696,110	0.0%	$10.9M	0.0%	$15.68	0
2023-Q4	New	696,110	-	$9.3M	0.0%	$13.42	38